Comparison of the New Oral Anticoagulants and Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: Systematic Review and Meta-Analysis.

New oral anticoagulants (NOACs) are approved for use in nonvalvular atrial fibrillation (AF).